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Introduction: Hughes-Stovin syndrome is a life-threatening disorder of unknown etiology. This condition
is characterized by vasculitis, deep venous thrombosis and aneurysms that mainly involve the pulmonary
arteries resulting in hemoptysis. It has been described in literature less than 40 times. However, we
believe it is not very uncommon as it might be diagnosed as pulmonary embolism solely. In such cases,
anticoagulation therapy augments the risk of life-threatening hemoptysis.
Materials and methods: We report the case of a 35 years old, Egyptian female patient with Hughes-Stovin
syndrome, who initially presented with lower limb deep vein thrombosis and coughing of blood. Anti-
coagulation regimen for pulmonary embolism was given. This resulted in massive hemoptysis that was
successfully controlled by medical therapy.
Conclusion: Adults who present with venous thrombosis and hemoptoic cough, with no predisposing
factors of thrombosis, normal platelet count and coagulation, the possibility of Hughes-Stovin syndrome
has to be considered.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hughes-Stovin syndrome (HSS) is a life-threatening disorder of
unknown etiology. This condition is usually presented by vasculitis,
deep venous thrombosis and aneurysms that usually involve the
pulmonary arteries as well as the bronchial arteries resulting in
hemoptysis. In such cases, using anticoagulant therapy might be
life-threatening as it augments the risk of hemoptysis [1,4].
2. Case report
A 35 years old female presented at the emergency room with
coughing of blood (about half a cup all over the day) associatedwith
bilateral below knee level non-pitting edema of two days' duration,
more evident on the right side. She reported that her illness started
four years ago by lower limb edema, tense and tender calf muscles
and was diagnosed as bilateral acute deep venous thrombosis. She
received anticoagulation therapy and stopped by herself after few
months. One year ago, she developed dyspnea on moderatedelbary).
Ltd. This is an open access article uexertion, hemoptoic cough, chest pain and erythema nodosum. At
that time, she was advised to take anti-inﬂammatory drugs and
steroids to control the erythema nodosum, underwent lower limb
duplex scan and multislice CT angiography of the pulmonary ar-
teries that revealed bilateral chronic DVT and bilateral pulmonary
embolism respectively. Vascular surgery didn't support the idea of
IVC ﬁlter placement and advised to keep the patient on LMWH that
resulted in partial improvement.
Based on the clinical presentation and patient's medical history
she was admitted, kept on LMWH 80 IU twice per day andWarfarin
5mg/day. A new lower limb venous duplex scan and Multislice CT
scan of the pulmonary arteries revealed Subacute bilateral DVT
with similar ﬁndings in the CT pulmonary angiography Which
stated the existence of thrombotic ﬁlling defects that involved the
main right pulmonary artery, extending partially into the
segmental lower lobe artery branches with adjacent ectatic bron-
chial arteries (Fig.1), alsowith a smaller thrombotic circumferential
ﬁlling defect at the left lower lobe artery branch, preserving a
centrally patent residual lumen (Fig. 2). Unfortunately, such ﬁnd-
ings of suspicious pulmonary aneurysms with thrombotic process
inside as well as dilated ectatic bronchial arteries could not be
correlated at the time of presentation to Hughes Stovin syndromender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. CT angiography of the pulmonary arteries (a) Axial view (b) Coronal view showing right main pulmonary artery aneurysm with circumferential thrombotic ﬁlling defect
(Thin arrows) and ectatic adjacent bronchial arteries (Thick arrows).
Fig. 2. CT angiography of the pulmonary arteries (a) Axial view (b) Coronal view showing left lower lobe pulmonary artery aneurysm with mural thrombotic ﬁlling defect (Thin
arrows).
Fig. 3. Catheter angiography of the pulmonary arteries(a) Right pulmonary artery aneurysm (thick arrow) with lower lobe perfusion defect (curved arrow) (b) Left segmental
pulmonary artery aneurysm (thick arrow).
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Associated clinical ﬁndings included few primary erythema
nodosum for which methylprednisolone 8mg 1 tablet/day and
colchicine 0.5 mg two tablets twice daily were given. Co-existing
vaginal bleeding was also investigated by transvaginal ultrasound
that revealed right-sided hemorrhagic ovarian cyst.Vital data and general laboratory work up like CBC, liver and
kidney functions, T3, T4 and TSH were all ﬁne. ESR was 74, ANA,
ANCA, Antiphospholipid antibody, lupus anticoagulant, anti-
cardiolipin, PCR for factor V and sputum culture and pathergy tests
were all negative. Patient was diagnosed as DVT with PE and
received the classical anticoagulation therapy, stayed in the
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After few days, hemoptoic cough stopped with remarkable
improvement of the limb swelling and tense calf muscles. A deci-
sion was made to discharge the patient on anticoagulation therapy
and monitor the coagulation proﬁle. One week later, she presented
with massive hemoptysis and hypovolemic shock that was medi-
cally corrected.
Bronchoscopy revealed dilated tortuous submucosal vessels on
the bronchus intermedius and lower lobe bronchi on the right side
as well as the anterior and posterior basal segments on the left side.
Moreover, the lateral wall of the lower lobe bronchus showed
submucosal pulsating bulge with free overlying mucosa. Such
ﬁndings of vascular malformation and aneurysmal dilatation were
highly consistent with the CT angiography ﬁndings, and biopsy was
avoided.
Conventional pulmonary angiography done on the next day for
detailed evaluation of the aneurysms and possibility of
embolization.
A multidisciplinary discussion between the pulmonologists,
thoracic surgeons and interventional radiologists ﬁnally decided
that either this case is a cardiovascular form of Behcet or Hughes
Stovin syndrome, anticoagulation therapy as well as any surgical or
interventional therapy must be primarily avoided. We also decided
to combine pulse therapy with methylprednisolone (1 g for three
days) and cyclophosphamide (1 g per monthly session) for initial
management and stabilization of the aneurysms. No attacks of
hemoptysis recurred and the patient was discharged. She did not
show up in the reconsultation dates. One year later, she got preg-
nant despite contraception yet spontaneous abortion occurred at
about 8 weeks. Her family reported shewas not totally compliant to
the given therapy and refuses the idea of trans-catheter emboli-
zation. Fortunately, she did not develop another attack of
hemoptysis.
3. Discussion
Hughes-Stovin syndrome is a life-threatening disorder of un-
known etiology. It has been described to be a variant of Behçet's
disease. Men aged between 12 and 40 years are the most likely
affected, and usually present with hemoptoic cough, dyspnea, chest
pain and signs of pulmonary hypertension following history of
deep venous thrombosis [1]. Prevalence is unknown but less than
35 cases have been published in literature since its ﬁrst description
in 1959 by Hughes and Stovin [2].
Hughes-Stovin syndrome clinically passes into three phases: a
ﬁrst phase involving symptoms of thrombophlebitis, a second
phase involving formation of pulmonary artery aneurysms, and a
third phase of aneurysmal rupture that results in massive hemop-
tysis that is usually fatal [3]. Accordingly, we do think that this
condition is not very uncommon. Patients presenting with
thrombophlebitis with or without chest pain, particularly those
who did not develop sizeable aneurysms, would mostly direct the
diagnosis and management towards pulmonary embolism and the
traditional anticoagulation therapy.
Aneurysms usually affect both the pulmonary and the bronchial
arteries resulting in hemoptysis. However, they might occur any-
where in systemic circulation [4]. Recurrent phlebitis is a common
associated ﬁnding that usually involves the large vessels resulting
in thrombus formation. Thrombosis of the vena cava and the right
atrium has also been reported [1e5]. Histologic studies showed
destruction of the arterial wall and perivascular lymphomonocytic
inﬁltration of capillaries and venules [6].
The existence of septic emboli and undetected organisms of
low-grade virulence has been suggested in the pathogenesis of the
pulmonary aneurysms. (Table 1). However, infectious agents, beingone of the etiological factors for HSS, have not been supported for
two reasons. Firstly, many antibiotic regimens that were tried
during the treatment of HSS were not effective. Secondly, no pos-
itive blood cultures have been obtained during the evaluation of
patients with HSS [4].
Currently the most supported opinion about the pathogenesis of
this condition is that Hughes-Stovin syndrome results from a
vasculitis similar to that occurring in Behçet's disease [1]. Vasculitis
in Behçet's disease particularly results in arterial occlusions, arterial
aneurysms, venous occlusions, and varices [7], denoting systemic
vessel involvement. In our case, Vasculitis of the peripheral veins
and the pulmonary arteries was the ﬁrst presenting sign and pre-
ceded the attack of hemoptysis by about four years. Furthermore, it
is very likely that Hughes-Stovin syndrome represents a cardio-
vascular manifestation of Behçet's disease, as in both clinical en-
tities, there is co-existence of pulmonary aneurysms [8]. (Table 2)
However, most of the reported cases of Hughes-Stovin syndrome,
including ours, were not found to fulﬁl the clinical manifestations
of Behçet's syndromedoral ulceration, recurrent genital ulcers, eye
and skin lesions [9].
Hemoptysis is the main cause of death in patients with Behçet's
disease. However, Hughes-Stovin syndrome is mostly fatal as a
result of large volumes of hemoptoic cough due to pulmonary/
bronchial arterial aneurysm rupture. Moreover, systemic bronchial
artery hypertrophy secondary to ischemia that occurs on top of
pulmonary artery occlusion could also be the origin of bleeding.
Nevertheless, it has been suggested that bronchial to pulmonary
shunting might occur secondary to pulmonary artery thrombosis
where existence of an iso-ﬂow and hypertrophy could result in
aneurysm formation as well [10]. In our case, ectatic bronchial ar-
teries were seen close to the sites of pulmonary artery aneurysms, a
ﬁnding that goes with the commonly described pathogenic factors
of the disease.
Mahlo et al. and Herb et al. also performed digital subtraction
angiography of the bronchial arteries and described the existence
of distorted and dilated bronchial arteries with convoluted small
branches. Mahlo et al. reported that the cause of death in many of
the previously encountered Hughes-Stovin cases is likely due to
ruptured angiodysplastic bronchial arteries rather than ruptured
pulmonary artery aneurysms [10]. Bronchial artery embolization
was performed in both cases and was considered an effective
therapeutic approach [11]. Finally, it has been suggested that he-
moptysis is likely occurring secondary to both pre-mentioned
pathogenic mechanisms [12].
Although conventional pulmonary angiography can be used for
better anatomical evaluation of the pulmonary aneurysms [13]. It
has been reported that multi-detector row helical CT angiography
could provide more precise and accurate visualization of bronchial
and non-bronchial systemic arteries than does conventional angi-
ography [14].
In our case CT angiography highlighted the existence of
thrombotic ﬁlling defects that involved the right main pulmonary
artery, extending partially into the segmental lower lobe artery
branches, also with a smaller thrombotic circumferential ﬁlling
defect at the left lower lobe artery branch with a centrally patent
residual lumen. Thus, the case was interpreted as pulmonary
thromboembolism with suspected pulmonary aneurysms and
adjacent ectatic bronchial arteries. However, the pulmonary an-
eurysms were strongly suggested during bronchoscopy performed
after an aggressive attack of hemoptysis. Conventional pulmonary
angiography was then performed to give a detailed description of
the pulmonary artery pathology and to assess for possibility of
embolization.
In our case, the circumferential ﬁlling defect at the left lower
lobe artery branch with the centrally patent residual lumen found
Table 1
Infectious agents involved in the pathogenesis of Behcet's disease (adopted from Umair K. and Taimur S [4].
Agents Pertinent rationale or refutation for involvement in Behcet's disease
Hepatitis A, B, C, E viruses Serological evidence of previous HAV, HCV and HEV infections showed no
signiﬁcant difference in patients with Behcet's disease compared to controls.
Previous HBV infection, however, seen in a remarkably lower number of
patients with Behcet's disease as compared with healthy controls.
Herpes simplex virus (HSV) Anti-HSV-1 antibodies were found more commonly in patients with Behcet's disease than controls.
DNA of HSV was detected in genital and intestinal ulcers but not in oral aphthous ulcers.
Parvovirus B19 Parvovirus B19 IgG antibodies were reported more in patients with Behcet's disease as compared to controls
Helicobacter pylori Almost the same proportion of patients with Behcet's disease and controls were found
to have H. pylori infection following eradication therapy.
Chlamydia pneumoniae IgG seropositivity for C. pneumoniae between cases and controls was not signiﬁcantly different.
However, the proportion of seropositive cases with higher IgG titres was greater.
Streptococcus sanguis,
Streptococcus mitis and
Streptococcus salivarius
Decline of skin and arthritic involvement in Behcet's disease after antibiotic administration.
Hypersensitivity to cutaneous streptococcal antigens was reported.
Aggravation of symptoms after dental procedures.
Treatment of chronic oral infections positively impacts long term prognosis of disease.
Saccharomyces cerevisiae Unclear role, distribution and pathogenetic relationship of ASCA antibodies in patients with Behcet's disease
Heat shock proteins Heat shock proteins of mycobacteria and streptococci were suggested to have a role in Behcet's disease.
Model of molecular mimicry thought to be responsible for manifestations of Behcet's disease.
Table 2
Similarities in pulmonary involvement between Behcet's disease and HSS (adopted from Umair K. and Taimur S) [4].
Characteristic Details
Gender Predominantly young males
Triad of clinical ﬁndings Fever, arthralgia's, thrombosis
Occurrence of thrombosis with pulmonary artery aneurysms HSS e 100%; Behcet's disease - 80%
Overlapping histopathologic features Destruction of arterial walls, perivascular inﬁltrates
Therapy Cytotoxic drugs and corticosteroids
Most common cause of death Rupture of pulmonary artery aneurysm
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inﬂammation of the pulmonary artery aneurysme such a ﬁnding is
not usually seen in isolated acute or chronic pulmonary embolism
[15]. Accordingly, the pathogenesis of pulmonary artery aneurysms
in Hughes-Stovin syndrome was attributed to weakening of the
vessel wall due to inﬂammation, which matches what Ketchum
et al. reported; that the aneurysms usually develop at the locations
of prior thrombus and abnormal enhancement [15].
In our case, the conventional angiography provided superior
images compared to those obtained by CT angiography as regards
the number, size and location of the pulmonary aneurysms, as well
as the accuracy in depicting the adjacent pathological bronchial
arteries. This agrees with what Remy-Jardin et al. mentioned [14].
However, we suggest that conventional angiography would be the
procedure of choice if lifesaving embolization is going to be carried
out.
Conventional angiography would not be applicable in all pa-
tients with venous thromboses. Contrast-Enhanced MRA and
Contrast-Enhanced MDCTA may provide an alternative [16,17].
Moreover, 3D volume rendering images can ideally visualize the
pathological bronchial arteries even before aneurysm formation
[15].
As only few cases were reported and no controlled trials have
been obtained, there is no standard therapy for Hughes-Stovin
syndrome. However, similar to the treatment regimen applied in
Behcet's disease, treatment of Hughes-Stovin syndrome with ste-
roids alone or in combination with immunosuppressant drugs, has
been suggested [18]. It has been found that the use of immuno-
suppressant drugs, either systemic corticosteroids or cytotoxic
agents (a combination of cyclophosphamide and glucocorticoids),
in patients with Hughes Stovin syndrome without or with small
amount of hemoptysis would positively impact the stability of the
pulmonary artery aneurysm walls, or even make them disappear[1] If pulmonary embolism is present a therapeutic dilemma often
occurs as regards the use of anticoagulants. This is what we faced in
our case as there was co-existing thromboembolism with right
lower lobe perfusion defect. Anticoagulation may prevent the
progression of pulmonary embolism and resolve vein thrombi, but
since it increases the risk and severity of hemoptysis, it is not rec-
ommended [4].
In our case, we aimed at stabilizing the wall of the aneurysms
and reducing the risk of rebleeding so we decided to avoid anti-
coagulation therapy as well as any surgical or interventional ther-
apy and to combine pulse therapy with methylprednisolone and
cyclophosphamide as an initial management. This also agrees with
the initial management protocol implemented by Umair K. and
Taimur S [4].
Surgical resection of the affected segments of the lung has also
been considered in cases of high risk rupture aneurysms limited to
one segment or one lung [8].
However, the high morbidity and mortality associated with
surgery, and the likelihood of multifocality and bilaterality of the
pulmonary artery aneurysms at the time of diagnosis, makes trans-
catheter embolization an alternative to surgery as a life saving
measure in many cases [1]. Identiﬁcation of aneurysms in the
bronchial arteries could be treated by bronchial artery embolization
[11]. Surgical or interventional management was also planned in
our case after 6 months of medical therapy aiming to stabilize the
aneurysm walls ﬁrst. However, as previously mentioned, the pa-
tient was not totally compliant to the given regimen and refused
any further investigations and possible intervention.
4. Conclusion
Hughes Stovin syndrome could be described as an isolated
cardiovascular form of Behcet's disease. Patients who present with
M. Abdelbary et al. / Respiratory Medicine Case Reports 19 (2016) 98e102102DVT and PE with no predisposing factor of thrombosis, whether
associated with hemoptysis or not, should be meticulously inves-
tigated for the coexistence of pulmonary artery aneurysms. Early
diagnosis and prompt treatment of HSS would greatly improve the
prognosis.
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